Commissioner Of CGST And Central Excise vs. Emcure Pharmaceuticals LTD Sidco Jammu

CEA/389/2022HC Jammu and Kashmir and LadakhGSTCNR JKHC02004036202212 December 2022Bench: HON'BLE THE CHIEF JUSTICE (ACTING),HON'BLE MR. JUSTICE RAJESH SEKHRI1 pages
AI SummaryDismissed

Held

The Court held that the present appeal is identical to several other Excise Appeals previously considered and decided by the Court in its judgment and order dated May 23, 2022, in CEA No. 10 of 2020 and connected appeals. Since no new grounds were presented by the appellant, the matter was squarely covered by the prior decision. The Court found no reason to deviate from its earlier findings. Accordingly, the appeal was dismissed on the same terms and conditions as laid down in the judgment and order dated May 23, 2022. The ratio decidendi is that appeals raising identical issues without new grounds are bound by previous judgments of the same court.

Facts

The Commissioner of Central GST and Central Excise, J&K Jammu (appellant) filed an appeal against Emcure Pharmaceuticals Ltd. (respondent). The appeal was identical to several other Excise Appeals previously considered and decided by the High Court of Jammu & Kashmir and Ladakh vide a judgment dated May 23, 2022, where CEA No. 10 of 2020 was the leading case. The appellant's counsel was heard, and the Court noted that no new grounds were available to the appellant. The matter was considered squarely covered by the aforementioned decision.

Key Issues

1. Whether the present appeal is covered by the judgment and order dated May 23, 2022, passed in CEA No. 10/2020 and connected appeals, given that the present appeal raises no new grounds. Contentions of the Appellant (Commissioner of Central GST and Central Excise): The appellant argued that the present appeal is identical to previous appeals that have already been decided by this Court. They contended that no new grounds have been presented in this appeal, and therefore, it should be decided in line with the previous judgments. Contentions of the Respondent (Emcure Pharmaceuticals Ltd.): The judgment does not record any specific arguments made by the respondent. However, the Court's decision implies that the respondent's position, as reflected in the prior judgments, was upheld.

AI-generated summary — verify with the full judgment below

Cause title — parties, addresses and appearances
HIGH COURT OF JAMMU & KASHMIR AND LADAKH AT JAMMU CEA No. 389/2022 CM No. 7284/2022 CM No. 7285/2022 Commissioner of Central GST and Central Excise J&K Jammu ….Petitioner(s)/Appellant(s) Through :- Mr. Jagpaul Singh, Advocate. V/s Emcure Pharmaceuticals LTD SIDCO Jammu ….Respondent(s) Through :- Mr. Rajnesh Singh Parihar, Advocate vice Mr. Gautam Chugh, Advocate. Coram: HON’BLE THE CHIEF JUSTICE (ACTING) HON’BLE MR. JUSTICE REJESH SEKHRI, JUDGE

ORDER 12.12.2022

1.

This appeal is similar and identical to the several other Excise Appeals which have been considered and decided by this Court vide judgment and order dated 23rd of May 2022 wherein CEA No. 10 of 2020 was the leading case.

2.

Having heard counsel for the appellant, we are of the opinion that as no new ground is available to the appellant, the matter stands squarely covered by the above decision.

3.

Accordingly, this appeal is dismissed on the same terms and conditions as laid down in the judgment and order dated 23rd of May, 2022 passed in CEA No. 10/2020 a

The judgment continues below.

Read the full judgment

A free account opens 10 full GST judgments a month (one account works on both bharattax.net and this site). Re-reading one you have already opened does not count again.

See plans and prices

The summary, the parties, the sections and the citations above are open to everyone and always will be. Only the text of the order and the PDF are metered.

Reproduced from the public record of the High Court of Jammu and Kashmir and Ladakh. Verify against the court's own copy before relying on it. Income tax judgments are on bharattax.net.